Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The future in the instant: The lung adenocarcinoma classification as a predictor of future adverse events

Lung Cancer(2021)10.1016/j.lungcan.2021.03.010Source: DataRank Database

The future in the instant: The lung adenocarcinoma classification as a predictor of future adverse events is a research paper published in Lung Cancer (2021). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

0 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.00)OA: closedTopics (26)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (1)

Raymond U. Osarogiagbon ORCID

Live enrichment

PubMed:33757658 OpenAlex:https://openalex.org/W3138210485

National Institutes of Health

Grant: R01CA172253

National Institutes of Health

Grant: UG1CA189873

National Institutes of Health

Grant: UM1CA233080

National Institutes of Health

FWCI

0.00

Citation Percentile

0.0%

closedLicense: https://www.elsevier.com/legal/tdmrep-license

publisherhttps://api.elsevier.com/content/article/PII:S0169500221001069?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0169500221001069?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.lungcan.2021.03.010

repositoryhttps://pubmed.ncbi.nlm.nih.gov/33757658

Fields of Study

Lung Cancer Treatments and MutationsLung Cancer Diagnosis and TreatmentLung Cancer Research Studies

MeSH Terms

Adenocarcinoma of LungAdenocarcinomaBrain NeoplasmsHumansLung NeoplasmsNeoplasms, Second Primary

Keywords

MedicineLung cancerInternal medicineOncologyBevacizumabCarboplatinGefitinibEpidermal growth factor receptorCrizotinibAnaplastic lymphoma kinaseAdenocarcinomaTargeted therapyPemetrexedCancerCancer researchChemotherapyMalignant pleural effusion

Sustainable Development Goals

SDG 0: Good health and well-being

The future in the instant: The lung adenocarcinoma classification as a predictor of future adverse events

FAIR Checklist

Authors (1)

Funding (4 grants)

Impact

Open Access

Topics